SMS Pharmaceuticals · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Middle East tensions causing sharp increases in solvent costs, which impacted Q4 gross margins on quarter-on-quarter basis. This external factor remains outside management control and could continue to pressure margins if conflict persists.
Single largest customer group accounts for 28% of total revenue across multiple products. Management declined to identify the customer. Concentration risk remains significant if this relationship weakens.
Existing capacity at 80% utilization while expansion is underway creates operational tightness. Any delays in the FY27 brownfield completion could impact volume growth and customer commitments already made for the year.
70% of revenue currently from exports, expected to rise to 75% with new API launches. Currency volatility and geopolitical logistics disruptions create dual exposure to export revenue and raw material imports.
